Improved Methods for Extracting RNA from Exfoliated Human Colonocytes in Stool and RT-PCR Analysis
- 184 Downloads
In order to diagnose colon cancer at an earlier, more localized stage, there is a need to develop diagnostic markers (genes) which can detect early patterns of gene expression in exfoliated colonocytes shed in the stool during routine screening for this disease. An RNA-based detection is more pertinent than either a DNA-based or a protein-based method as a screening procedure, but it has not been widely used as a cancer screen because of the difficulty of handling and stabilizing the RNA molecule. We describe a method that permits extraction of intact nondegraded total RNA from human colonocytes in stool and from normal and malignant colon tissues (which were employed for comparison with stool). Because it utilizes commercially available kits, this method is simpler than other published methods and does not require isolation of messenger (m)RNA, thereby reducing the chances of contaminating the preparations with degrading nucleases, and even a small amount of isolated total RNA can be adequately reverse transcribed, making high-quality copy (c) DNA. This is followed by PCR (either qualitative end point or semiquantitative real-time) using colon cancer-specific gene primers. By routinely and systematically being able to perform quantitative gene expression measurements on noninvasive samples, the goal of this pilot work is to lay the groundwork for conducting a large clinical study to identify groups of selected genes whose expression is consistently altered at an early stage in the neoplastic process. Such work will permit noninvasive monitoring of at-risk patients through the analysis of their stool samples. Correct diagnosis will allow for surgical and/or other interventions before the tumor is well established and, thus, should decrease mortality from this preventable disease.
Unable to display preview. Download preview PDF.
- 2.Smith RA, von Eschenbach AC, Wender R, Levin B, Byers T, Rothenberger D, Brooks D, Creasman W, Cohen C, Runowicz C, Saslow D, Cokkinides V: American Cancer Society guidelines for the early detection of cancer: Update of the early detection guidelines for prostate, colorectal and endometrial cancers. CA Cancer J Clin 51:38–75, 2001PubMedGoogle Scholar
- 4.Towbridge B, Burt RW: Colorectal cancer screening. Surg Clin No Am 82:943–957, 2002Google Scholar
- 11.Santiago ML, Bibollet-Ruyde F, Bailes E, Kamenya S, Muler MN, Lukasik M, Pusey AE, Collins DA, Wrangham RW, Goodall J, Shaw GM, Sharp PM, Hahn BH: Amplification of a complete simian immunodeficiency virus genome from fecal RNA of a wild chimpanzee. J Virol 77:2233–2242, 2003CrossRefPubMedGoogle Scholar
- 14.Owens AH, Coffey DS, Baylin SB: Tumor Cell Heterogeneity: Origins and Implications. New York, Academic Press, 1982Google Scholar
- 19.Kuecker SJ, Jin L, Kulig E, Oudrago GL, Roche PC, Lloyd RV: Analysis of PRL, PRL-R, TGFβ1 and TGFβ-RII gene expression in normal neoplastic breast tissue after laser capture microdissection. Appl Immunol Mol Morph 7:193–200, 1999Google Scholar
- 20.Cagir B, Gelmann A, Park J: Gunaylyl cyclase c messenger RNA is a biomarker for recurrent stage II colorectal cancer. Ann Intern Med 131:806–812, 1999Google Scholar
- 24.Albaugh GP, Igenyar V, Lohani A, Malayeri M, Bala S, Nair PP: Isolation of exfoliated colonic epithelial cells, a novel non-invasive approach to the study of cellular markers. Int J Cancer 52:342–350, 1992Google Scholar
- 29.Heid CA, Stevens J, Livak KJ, Williams PM: Real-time quantitative PCR. Genome Res 6:986–994, 1998Google Scholar